Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: MissionIR

Rising Demand for Physical Metals Boosts Platinum’s Investment Appeal

Posted on November 6, 2024 by MissionIR

As economic uncertainties loom, investors are increasingly gravitating toward tangible assets, with physical metals emerging as a standout choice. This trend has become so significant that even major retailers, such as Costco (NASDAQ: COST), are entering the precious metals market … Continue reading →

Posted in Platinum Group Metals Ltd. PLG | Leave a comment

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Deemed “Awardable” by DoD’s Tradewinds Solutions Marketplace

Posted on November 6, 2024 by MissionIR

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”) announced it has achieved “Awardable” status in the US Department of Defense’s (DoD) Tradewinds Solutions Marketplace, which showcases cutting-edge technologies for potential DoD adoption. This designation endorses D-Wave’s annealing quantum computing technology as a vetted … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

Annovis Bio Inc. (NYSE: ANVS) Highlights Buntanetap Results at 17th Clinical Trials on Alzheimer’s Disease (‘CTAD’) 2024 Conference

Posted on November 5, 2024 by MissionIR

Annovis (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), presented two scientific posters at the 17th Clinical Trials on Alzheimer’s Disease (“CTAD”) conference (https://ibn.fm/ysPFn), held … Continue reading →

Posted in Annovis Bio Inc. ANVS | Leave a comment

The US Announces New Strategy to Help It Dominate the AI Race

Posted on November 1, 2024 by MissionIR

President Biden has rolled out a new plan aimed at enabling the U.S. to harness AI for national security purposes amid a global race that is seeing different countries scrambling to tap this new technology for their own interests. He … Continue reading →

Posted in McEwen Mining Inc. MUX | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Granted Nasdaq Extension for Compliance 

Posted on November 1, 2024 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP) announced that it received an exception from the Nasdaq Hearings Panel, granting the company until March 11, 2025, to meet the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This extension allows CNS additional time … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – SOBRsafe Inc. (NASDAQ: SOBR) Secures Nasdaq Compliance, Continues Listing Under Monitoring Period

Posted on November 1, 2024 by MissionIR

SOBRsafe (NASDAQ: SOBR) announced its compliance with Nasdaq’s listing standards, meeting minimum bid price, public float, and stockholders’ equity requirements per the August 2024 Nasdaq Hearings Panel decision. As a result, SOBRsafe’s common stock will remain listed on the Nasdaq … Continue reading →

Posted in SOBRsafe Inc. SOBR | Leave a comment

MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q3 Earnings Call with Key Regulatory and Initiative Updates

Posted on October 31, 2024 by MissionIR

HeartBeam (NASDAQ: BEAT), a medical technology company focused on enhancing cardiac care through advanced insights, will hold a conference call on November 7, 2024, at 4:30 p.m. ET to discuss third-quarter results and share updates on regulatory developments and ongoing … Continue reading →

Posted in HeartBeam Inc. BEAT | Leave a comment

MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) CEO Details Promising Phase 3 Path for Alzheimer’s Treatment on The BioMedWire Podcast

Posted on October 31, 2024 by MissionIR

Annovis Bio (NYSE: ANVS) led by Founder, President and CEO Dr. Maria Maccecchini, shares exciting developments regarding its pioneering Alzheimer’s and Parkinson’s drug candidate, buntanetap. In her interview on IBN’s BioMedWire Podcast, Dr. Maccecchini discusses Annovis Bio’s recent FDA clearance … Continue reading →

Posted in Annovis Bio Inc. ANVS | Leave a comment

MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Moving Closer to Providing Much-Needed Treatments to Patients

Posted on October 29, 2024 by MissionIR

Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering novel therapies for neurodegenerative diseases. Recent clinical trials of the company’s lead compound yielded encouraging results, with buntanetap shown to improve cognition in both Alzheimer’s and Parkinson’s patients. … Continue reading →

Posted in Annovis Bio Inc. ANVS | Leave a comment

Tiny Island in the Caribbean Gets Windfall as AI Boom Gathers Steam

Posted on October 28, 2024 by MissionIR

While it is common knowledge that investors in tech firms like Nvidia Corp. (NASDAQ: NVDA) are accumulating fortunes from AI, the island of Anguilla is also minting serious cash from this industry. This started at about the time ChatGPT went … Continue reading →

Posted in McEwen Mining Inc. MUX | Leave a comment